5-129396979-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000723046.1(ADAMTS19-AS1):​n.137-44844T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 152,320 control chromosomes in the GnomAD database, including 9,912 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 9893 hom., cov: 31)
Exomes 𝑓: 0.31 ( 19 hom. )

Consequence

ADAMTS19-AS1
ENST00000723046.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.140

Publications

3 publications found
Variant links:
Genes affected
ADAMTS19-AS1 (HGNC:40797): (ADAMTS19 antisense RNA 1)
MIR4460 (HGNC:41795): (microRNA 4460) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR4460NR_039665.1 linkn.*83T>C downstream_gene_variant
MIR4460unassigned_transcript_858 n.*136T>C downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS19-AS1ENST00000723046.1 linkn.137-44844T>C intron_variant Intron 2 of 2
ADAMTS19-AS1ENST00000723047.1 linkn.1062-35405T>C intron_variant Intron 5 of 6
MIR4460ENST00000577862.1 linkn.*83T>C downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.328
AC:
49850
AN:
151858
Hom.:
9888
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0985
Gnomad AMI
AF:
0.503
Gnomad AMR
AF:
0.421
Gnomad ASJ
AF:
0.383
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.363
GnomAD4 exome
AF:
0.314
AC:
108
AN:
344
Hom.:
19
AF XY:
0.300
AC XY:
57
AN XY:
190
show subpopulations
African (AFR)
AF:
0.250
AC:
3
AN:
12
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.375
AC:
3
AN:
8
European-Finnish (FIN)
AF:
0.750
AC:
3
AN:
4
Middle Eastern (MID)
AF:
0.302
AC:
84
AN:
278
European-Non Finnish (NFE)
AF:
0.417
AC:
5
AN:
12
Other (OTH)
AF:
0.333
AC:
10
AN:
30
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.328
AC:
49860
AN:
151976
Hom.:
9893
Cov.:
31
AF XY:
0.333
AC XY:
24701
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.0984
AC:
4086
AN:
41544
American (AMR)
AF:
0.421
AC:
6437
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.383
AC:
1328
AN:
3468
East Asian (EAS)
AF:
0.221
AC:
1123
AN:
5080
South Asian (SAS)
AF:
0.315
AC:
1515
AN:
4812
European-Finnish (FIN)
AF:
0.518
AC:
5468
AN:
10558
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28606
AN:
67932
Other (OTH)
AF:
0.358
AC:
754
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1530
3060
4589
6119
7649
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.377
Hom.:
17261
Bravo
AF:
0.313
Asia WGS
AF:
0.242
AC:
845
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.0
DANN
Benign
0.32
PhyloP100
0.14

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13171514; hg19: chr5-128732672; API